Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

22,543 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Preparing A Promising Drug Candidate For ANDA Litigation - Part 2

    If you read part one of this series, you appreciate that it is imperative that all individuals involved in drug development — including scientific, regulatory, marketing, and financial personnel...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Results From Early PTAB Decisions On Inter Partes Review Petitions

    Based on a review of early results of PTAB's decisions on inter partes reviews, IP Litigation Partner and Chair of Foley's Patent Office Trials Practice Matthew A. Smith has authored a short article providing summary statistics and observations on the characteristics of successful petitions.
    United StatesFood, Drugs, Healthcare, Life Sciences
Foley & Lardner LLP
Foley & Lardner LLP
  • Article

    The Bio/Pharma Beat - January 2020

    We would like to share with you the Bio/Pharma Beat, our monthly newsletter reporting on the patent law developments you should know in biotech, biologics and pharmaceutical cases, legislation and federal agency actions.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Squire Patton Boggs LLP
    Squire Patton Boggs LLP
  • Article

    Why Cannabis Patent Enforcement Is In The Weeds

    The article "Why Cannabis Patent Enforcement is in the Weeds," written by Daniel Pereira and contributed to by summer associate Alec Royka, is featured by Managing Intellectual Property.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Oblon
    Oblon
  • Article

    GAO Invokes Rare Exception To Protest Timeliness Rule

    This article examines the GAO's decision in the Eastern Forestry case. Additionally, this article takes the opportunity to examine the parameters of the "limited time period" exception generally.
    United StatesGovernment, Public Sector
    Bradley Arant Boult Cummings LLP
    Bradley Arant Boult Cummings LLP
  • Article

    Senate Passes Patent Reform

    On Thursday, September 8th, the United States Senate passed the America Invents Act (H.R. 1249) in a bipartisan 89–9 vote.
    United StatesGovernment, Public Sector
    Venable LLP
    Venable LLP
  • Article

    Ride-Through Revisited (Again) — The Strategic Use Of The Ride-through Doctrine In The Post-Catapult Era

    The so-called "hypothetical test" adopted in cases such as Catapult and Sunterra has been widely criticized as potentially preventing a debtor-in-possession from continuing to use certain unassignable contracts.
    United StatesInsolvency/Bankruptcy/Re-Structuring
    Fox Rothschild LLP
    Fox Rothschild LLP
  • Article

    #FlashbackFriday Patents: Velcro

    A patent for this handy invention was granted this week in 1955.
    United StatesIntellectual Property
    Troutman Pepper Locke LLP
    Troutman Pepper Locke LLP
  • Article

    3 Trends That Could Lead To More Auto Patent Litigation

    Historically, there has been relatively little patent litigation between automotive companies, particularly when compared to competitors in other industries, such as consumer electronics and pharmaceuticals.
    United StatesIntellectual Property
    WilmerHale
    WilmerHale
  • Article

    Judge Andrews Denies Motion For Attorneys' Fees Of Prevailing Party But Awards Costs

    Gregory B. Williams' blog post, "Judge Andrews Denies Motion For Attorneys' Fees Of Prevailing Party But Awards Costs" from the firm's Delaware Intellectual Property Litigation blog was featured in IPFrontline on February 24, 2016.
    United StatesIntellectual Property
    Fox Rothschild LLP
    Fox Rothschild LLP
  • Article

    5 Emerging Tech Trends Shaping IP

    Emerging technologies continue to reshape industries and societies, introducing unprecedented advancements that are changing the way we work and live. At the same time...
    United StatesIntellectual Property
    Greenberg Traurig
    Greenberg Traurig
  • Article

    5 Ways Recent Appellate Rulings Can Affect Your Patent Case

    The last three years have seen substantial developments in how patent infringement cases are tried.
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    A Broader View Of Analogous Prior Art

    In Unwired Planet, LLC v. Google Inc., the Federal Circuit affirmed the PTAB's holding that the patent was invalid as obviousness, agreeing that a cited prior art reference was analogous prior art.
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    A Patent Landscape Analysis: iPSCs

    There are several emerging technology clusters in the induced pluripotent stem cell space.
    United StatesIntellectual Property
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    A Patent Practice Overview With Partner Jeffrey Berkowitz

    Michael Rubin, Fordham Intellectual Property, Media & Entertainment Law Journal (IPLJ) staff member, sits down with Finnegan partner Jeffrey Berkowitz to discuss experiences encountered
    United StatesIntellectual Property
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    Adapting To The New Normal - U.S. Patent Practice In The Age Of COVID-19 Global Pandemic

    Yuki Onoe & Eric Schweibenz co-authored the article "Adapting to the New Normal – U.S. Patent Practice in the Age of COVID-19 Global Pandemic."
    United StatesIntellectual Property
    Oblon
    Oblon
  • Article

    After Bench Trial, Judge Sleet Concludes That None Of The Asserted Claims Of The Patents-In-Suit Are Invalid Due To Obviousness

    In Pfizer Inc., et al. v. Mylan Pharmaceuticals Inc., the Court concluded that the asserted claims of the patents-in-suit are invalid due to obviousness.
    United StatesIntellectual Property
    Fox Rothschild LLP
    Fox Rothschild LLP
  • Article

    ALJ: Complainant Waived Work Product Protection, ITC Blog

    On January 13, Judge Lord issued the public version of Order 50 in Certain Semiconductor Devices, Semiconductor Device Packages, And Products Containing Same, Inv. 337-TA-1010.
    United StatesIntellectual Property
    Jones Day
    Jones Day
  • Article

    ALJ Rogers Grants Sony's Opposed Motion For Termination Based On A Consent Order

    On September 5, 2012, ALJ Pender granted respondents Sony Corporation and Sony Corporation of America’s motion for termination of Inv. No. 337-TA-807.
    United StatesIntellectual Property
    McDermott Will & Emery
    McDermott Will & Emery
  • Article

    All Or Nothing: Why The Supreme Court SAS Mandate Does Not Eliminate The Shaw Safe Harbor

    Why The Supreme Court SAS Mandate Does Not Eliminate The Shaw Safe Harbor.
    United StatesIntellectual Property
    Jones Day
    Jones Day
  • Showing 301–320 of 22543 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics